PMID: 9640191Jun 26, 1998Paper

Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project

The British Journal of Ophthalmology
C A McCartyH R Taylor

Abstract

The use of eye care services by people with and without diabetes was investigated in the Melbourne Visual Impairment Project (VIP), a population based study of eye disease in a representative sample of Melbourne residents 40 years of age and older. A comprehensive interview was employed to elicit information on history of diabetes, medication use, most recent visit to an ophthalmologist and optometrist, and basic demographic details. Presence and extent of diabetic retinopathy was determined by dilated fundus examination. The Melbourne VIP comprised 3271 people who ranged in age from 40 to 98 years; 46.2% of them were male. Of 3189 people who had the fundus examination and knew their diabetes status, 162 (5.1%) reported having been previously diagnosed with diabetes and, of these, 37 (22.2%) were found to have diabetic retinopathy. Seven people (4.3%) had developed diabetes before age 30. The mean duration of diabetes was 9.2 years. People with diabetes were significantly more likely to have visited an ophthalmologist ever or in the past 2 years than people without diabetes. However, 31.8% of people with diabetes had never visited an ophthalmologist. The proportion of people who had never seen an ophthalmologist was 47.1% for p...Continue Reading

References

Nov 11, 1989·BMJ : British Medical Journal·T E RohanN J Wald
Nov 1, 1986·British Medical Journal·R WilliamsG Thompson
Jan 1, 1984·Ophthalmology·R KleinS E Moss
May 18, 1984·JAMA : the Journal of the American Medical Association·S R Witkin, R Klein
Jul 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·E AgardhC Hansson-Lundblad
Oct 13, 1993·JAMA : the Journal of the American Medical Association·R J BrechnerM I Harris
Mar 10, 1993·JAMA : the Journal of the American Medical Association·F L Ferris
Dec 1, 1994·Ophthalmic Epidemiology·P M LivingstonH R Taylor

❮ Previous
Next ❯

Citations

Feb 18, 2009·International Ophthalmology·Xiwei XieJost B Jonas
Jul 22, 2008·Irish Journal of Medical Science·E DervanD O'Shea
Sep 11, 2003·Diabetes Research and Clinical Practice·F El FakiriM Rijken
Aug 8, 2001·The Australian Journal of Rural Health·S J LeeJ E Keeffe
Dec 3, 2003·The Australian Journal of Rural Health·Donna B MakIan McAllister
Jun 18, 1998·Australian and New Zealand Journal of Ophthalmology·C A HarperH R Taylor
Dec 17, 2002·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Arthur Stevens
Jan 30, 1999·The British Journal of Ophthalmology·P M LivingstonH R Taylor
Jul 22, 1999·The British Journal of Ophthalmology·L DandonaG N Rao
Jul 25, 2000·The British Journal of Ophthalmology·R McKayH R Taylor
Feb 27, 2001·The British Journal of Ophthalmology·H R Taylor, J E Keeffe
Jan 22, 2002·The British Journal of Ophthalmology·Jill E KeeffeHugh R Taylor
Aug 20, 2002·The British Journal of Ophthalmology·V NarendranR D Thulasiraj
Jun 1, 2012·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Philip HooperDavid A L Maberley
May 18, 2010·Ophthalmology·Dandan WangNathan Congdon
Jan 23, 2016·Journal of Diabetes Research·Nicola M GlassonSarah L Larkins
Sep 10, 2008·Primary Care Diabetes·Enrique Soto-Pedre, Maria C Hernaez-Ortega
Mar 20, 2003·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Katrina L SchmidCarol Pedersen
Apr 24, 2008·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Jackie M StreetJanet E Hiller
Oct 19, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·P P-C ChiangT Y Wong
Jan 5, 2011·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Mavis M Y FungKaren K Y Cheng
May 19, 2012·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Sven-Erik BursellAlicia Jenkins
Jun 21, 2012·Clinical & Experimental Ophthalmology·Andrea I BoudvilleHugh R Taylor
Feb 3, 2015·Clinical & Experimental Ophthalmology·Robyn J TappHugh R Taylor
May 12, 2012·Contemporary Clinical Trials·Deborah A AskewClaire L Jackson
Feb 28, 2004·Diabetes Care·Robyn J TappUNKNOWN Australian Diabetes Obesity and Lifestyle Study Group
Jun 19, 2016·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Davin JohnsonRobert J Campbell
Oct 1, 2003·Clinical & Experimental Ophthalmology·Daniel J McCartyCatherine A McCarty
Sep 12, 2000·Clinical & Experimental Ophthalmology·S J LeeJ E Keeffe
Jul 12, 2001·Clinical & Experimental Ophthalmology·S E WrightUNKNOWN Working Group for the Evaluation of NHMRC Retinopathy Guideline Distribution
Nov 26, 1999·Australian and New Zealand Journal of Ophthalmology·J J WangW Smith
Sep 12, 2000·Clinical & Experimental Ophthalmology·H R NottleJ E Keeffe
Mar 29, 2001·Clinical & Experimental Ophthalmology·C A McCartyJ E Keeffe
Jul 29, 2006·Clinical & Experimental Ophthalmology·Andreas MüllerHugh R Taylor
Jun 2, 2007·Clinical & Experimental Ophthalmology·Andreas MüllerHugh R Taylor
Jul 27, 2005·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Brian D PuentDavid M Nondahl
Feb 28, 2006·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Andreas MüllerJill Elizabeth Keeffe
May 10, 2006·Expert Review of Medical Devices·Stephen H Sinclair
Sep 23, 1998·Australian and New Zealand Journal of Public Health·P M LivingstonH R Taylor
Feb 5, 2013·The Medical Journal of Australia·Melanie F LarizzaEcosse L Lamoureux
May 9, 2001·Clinical & Experimental Ophthalmology·C BalaP J McCluskey
May 9, 2001·Clinical & Experimental Ophthalmology·C A McCartyUNKNOWN Working Group on Evaluation of NHMRC Diabetic Retinopathy Guidelines
May 12, 2017·The Medical Journal of Australia·Joshua ForemanMohamed Dirani
Dec 10, 2008·Ophthalmic Epidemiology·Xinzhi ZhangPaul P Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
M TrentoM Porta
Clinical & Experimental Optometry : Journal of the Australian Optometrical Association
Ruth Colagiuri
© 2022 Meta ULC. All rights reserved